Additive Manufacturing Technologies for Drug Delivery Applications.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Apr 2020
Historique:
received: 02 01 2020
revised: 06 03 2020
accepted: 18 03 2020
pubmed: 24 3 2020
medline: 16 1 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

Patient to patient variability is one of the issues when administering medications to individuals with different health conditions, pharmacokinetic, age, fitness, gender, and race. This requires introducing smart and personalised drug delivery systems with controlled release profile manufactured using novel approaches. Additive manufacturing (AM) provides opportunities such as full customisation, design freedom, and on-site manufacturing, and materials recycling. As a result, the academic and industrial demand for additive manufacturing for drug delivery has been continuously increasing and showing impressive results for a wide range of products. This paper provides an extensive overview of AM technologies and their applications for drug delivery. The review discusses AM technologies including their working principles, processed materials, as well as current progress in drug delivery to produce personalized dosages for every patient with controlled release profile. AM potentials, industrial scale, and challenges are investigated with regards to practice and industrial applications. The paper covers novel possibilities of AM technologies and their pharmaceuticals applications, which indicate a promising healthcare future.

Identifiants

pubmed: 32201252
pii: S0378-5173(20)30229-5
doi: 10.1016/j.ijpharm.2020.119245
pii:
doi:

Substances chimiques

Delayed-Action Preparations 0
Pharmaceutical Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

119245

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Abdullah Mohammed (A)

School of Engineering, University of Liverpool, Liverpool, L69 7ZX, UK.

Amr Elshaer (A)

Drug Discovery, Delivery and Patient Care (DDDPC), School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames, Surrey, KT1 2EE, UK.

Pooya Sareh (P)

School of Engineering, University of Liverpool, Liverpool, L69 7ZX, UK.

Mahmoud Elsayed (M)

Department of Industrial Engineering, Arab Academy for Science Technology and Maritime, Alexandria, Egypt.

Hany Hassanin (H)

School of Engineering, University of Liverpool, Liverpool, L69 7ZX, UK. Electronic address: h.hassanin@liverpool.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH